Angiosoma Stock Net Income
| GSTC Stock | USD 0.0001 0.00 0.00% |
AngioSoma technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
AngioSoma's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing AngioSoma's valuation are provided below:AngioSoma does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. AngioSoma |
AngioSoma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to AngioSoma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of AngioSoma.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in AngioSoma on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding AngioSoma or generate 0.0% return on investment in AngioSoma over 90 days. GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulatio... More
AngioSoma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure AngioSoma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess AngioSoma upside and downside potential and time the market with a certain degree of confidence.
AngioSoma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for AngioSoma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as AngioSoma's standard deviation. In reality, there are many statistical measures that can use AngioSoma historical prices to predict the future AngioSoma's volatility.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AngioSoma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
AngioSoma Backtested Returns
We have found three technical indicators for AngioSoma, which you can use to evaluate the volatility of the firm. The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and AngioSoma are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
AngioSoma has perfect predictability. Overlapping area represents the amount of predictability between AngioSoma time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of AngioSoma price movement. The serial correlation of 1.0 indicates that 100.0% of current AngioSoma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, AngioSoma reported net income of (1.49 Million). This is 100.44% lower than that of the sector and 102.12% lower than that of the Net Income industry. The net income for all United States stocks is 100.26% higher than that of the company.
AngioSoma Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AngioSoma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of AngioSoma could also be used in its relative valuation, which is a method of valuing AngioSoma by comparing valuation metrics of similar companies.AngioSoma is currently under evaluation in net income category among its peers.
AngioSoma Fundamentals
| Return On Asset | -44.28 | |||
| Current Valuation | 9.39 M | |||
| Shares Outstanding | 770.36 M | |||
| Shares Owned By Insiders | 10.02 % | |||
| Shares Owned By Institutions | 0.02 % | |||
| Price To Sales | 78,201 X | |||
| Gross Profit | (2.41 K) | |||
| EBITDA | (1.21 M) | |||
| Net Income | (1.49 M) | |||
| Cash And Equivalents | 12 | |||
| Total Debt | 20 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (327 K) | |||
| Earnings Per Share | (0.02) X | |||
| Price To Earnings To Growth | (0.08) X | |||
| Beta | 1.17 | |||
| Market Capitalization | 8.47 M | |||
| Total Asset | 9 | |||
| Net Asset | 9 |
About AngioSoma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze AngioSoma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AngioSoma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AngioSoma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in AngioSoma Pink Sheet
AngioSoma financial ratios help investors to determine whether AngioSoma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AngioSoma with respect to the benefits of owning AngioSoma security.